This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-361-5p | ABCA1 | 0.97 | 0 | -0.71 | 0.00276 | miRanda; mirMAP | -0.32 | 0 | NA | |
2 | hsa-miR-361-5p | ABCA8 | 0.97 | 0 | -5.33 | 0 | miRanda | -0.7 | 0.00034 | NA | |
3 | hsa-miR-361-5p | ABCD2 | 0.97 | 0 | -3.08 | 0 | miRanda | -1.28 | 0 | NA | |
4 | hsa-miR-361-5p | ABL1 | 0.97 | 0 | -1.32 | 0 | miRanda | -0.32 | 0 | NA | |
5 | hsa-miR-361-5p | ABL2 | 0.97 | 0 | -0.32 | 0.04554 | mirMAP | -0.15 | 0.00146 | NA | |
6 | hsa-miR-361-5p | ACACB | 0.97 | 0 | -2.93 | 0 | miRanda | -0.48 | 0 | NA | |
7 | hsa-miR-361-5p | ACTC1 | 0.97 | 0 | -7.19 | 0 | miRanda; miRNATAP | -3.21 | 0 | NA | |
8 | hsa-miR-361-5p | ACTN4 | 0.97 | 0 | -0.06 | 0.65476 | miRanda | -0.18 | 1.0E-5 | NA | |
9 | hsa-miR-361-5p | ADAM12 | 0.97 | 0 | 0.88 | 0.05623 | miRanda | -0.82 | 0 | NA | |
10 | hsa-miR-361-5p | ADAM19 | 0.97 | 0 | -1.06 | 0.01895 | miRanda | -1.17 | 0 | NA | |
11 | hsa-miR-361-5p | ADAM28 | 0.97 | 0 | -0.73 | 0.15943 | mirMAP | -0.49 | 0.00113 | NA | |
12 | hsa-miR-361-5p | ADAMTS5 | 0.97 | 0 | -2.16 | 0 | PITA; miRanda | -0.64 | 0 | NA | |
13 | hsa-miR-361-5p | ADCY2 | 0.97 | 0 | -3.87 | 0 | MirTarget; PITA; miRanda; miRNATAP | -1.04 | 0 | NA | |
14 | hsa-miR-361-5p | ADCY9 | 0.97 | 0 | -1.5 | 0 | miRanda | -0.65 | 0 | NA | |
15 | hsa-miR-361-5p | ADCYAP1 | 0.97 | 0 | -3.51 | 0 | miRanda | -0.98 | 0 | NA | |
16 | hsa-miR-361-5p | ADORA1 | 0.97 | 0 | 0.39 | 0.31104 | miRanda | -0.57 | 0 | NA | |
17 | hsa-miR-361-5p | ADRA2A | 0.97 | 0 | -2.58 | 0 | miRanda | -0.88 | 0 | NA | |
18 | hsa-miR-361-5p | AFF4 | 0.97 | 0 | -0.82 | 0 | miRanda | -0.1 | 0.02408 | NA | |
19 | hsa-miR-361-5p | AGPS | 0.97 | 0 | -0.1 | 0.48101 | miRanda; miRNATAP | -0.13 | 0.00105 | NA | |
20 | hsa-miR-361-5p | AHNAK | 0.97 | 0 | -1.66 | 0 | miRanda | -0.55 | 0 | NA | |
21 | hsa-miR-361-5p | AIDA | 0.97 | 0 | -0.31 | 0.01307 | miRanda | -0.22 | 0 | NA | |
22 | hsa-miR-361-5p | AJAP1 | 0.97 | 0 | -1.65 | 0.0004 | miRanda | -0.38 | 0.0057 | NA | |
23 | hsa-miR-361-5p | AKAP11 | 0.97 | 0 | -0.8 | 0 | mirMAP | -0.16 | 0.00083 | NA | |
24 | hsa-miR-361-5p | AKAP12 | 0.97 | 0 | -2.95 | 0 | miRanda | -0.63 | 0 | NA | |
25 | hsa-miR-361-5p | AKAP5 | 0.97 | 0 | 0.05 | 0.84509 | miRanda | -0.19 | 0.02017 | NA | |
26 | hsa-miR-361-5p | AKAP6 | 0.97 | 0 | -3.34 | 0 | miRanda | -1.09 | 0 | NA | |
27 | hsa-miR-361-5p | AKR1B10 | 0.97 | 0 | -3.05 | 0.00095 | miRanda | -0.69 | 0.01017 | NA | |
28 | hsa-miR-361-5p | ALDH1L2 | 0.97 | 0 | -1.12 | 0.02448 | miRanda; mirMAP; miRNATAP | -1.11 | 0 | NA | |
29 | hsa-miR-361-5p | ANGPT1 | 0.97 | 0 | -2 | 1.0E-5 | miRanda | -0.48 | 0.00023 | NA | |
30 | hsa-miR-361-5p | ANGPTL2 | 0.97 | 0 | -1.73 | 0 | miRanda | -1.12 | 0 | NA | |
31 | hsa-miR-361-5p | ANKRD44 | 0.97 | 0 | -1.93 | 0 | miRanda | -0.64 | 0 | NA | |
32 | hsa-miR-361-5p | ANO1 | 0.97 | 0 | 1.02 | 0.02235 | miRanda; miRNATAP | -0.27 | 0.0388 | NA | |
33 | hsa-miR-361-5p | ANO6 | 0.97 | 0 | -0.74 | 3.0E-5 | MirTarget; miRanda | -0.15 | 0.00429 | NA | |
34 | hsa-miR-361-5p | AOC3 | 0.97 | 0 | -3.69 | 0 | MirTarget; miRanda | -1.22 | 0 | NA | |
35 | hsa-miR-361-5p | AP1S2 | 0.97 | 0 | -1.31 | 0 | miRanda | -0.54 | 0 | NA | |
36 | hsa-miR-361-5p | AP3S1 | 0.97 | 0 | -0.06 | 0.68914 | miRanda | -0.15 | 0.0004 | NA | |
37 | hsa-miR-361-5p | AP4S1 | 0.97 | 0 | -0.6 | 0.00055 | miRanda | -0.21 | 3.0E-5 | NA | |
38 | hsa-miR-361-5p | APBB2 | 0.97 | 0 | -0.59 | 0.0014 | miRanda | -0.34 | 0 | NA | |
39 | hsa-miR-361-5p | APOLD1 | 0.97 | 0 | -2.62 | 0 | miRanda | -0.47 | 0 | NA | |
40 | hsa-miR-361-5p | AQP9 | 0.97 | 0 | 0.86 | 0.13122 | miRanda | -1.04 | 0 | NA | |
41 | hsa-miR-361-5p | ARF4 | 0.97 | 0 | 0.06 | 0.68077 | miRNAWalker2 validate; miRanda | -0.12 | 0.00153 | NA | |
42 | hsa-miR-361-5p | ARFGAP3 | 0.97 | 0 | -0.25 | 0.10361 | miRanda | -0.22 | 0 | NA | |
43 | hsa-miR-361-5p | ARHGAP15 | 0.97 | 0 | -1.33 | 0.00101 | miRanda | -0.79 | 0 | NA | |
44 | hsa-miR-361-5p | ARHGAP20 | 0.97 | 0 | -3.52 | 0 | miRanda | -1.28 | 0 | NA | |
45 | hsa-miR-361-5p | ARHGAP21 | 0.97 | 0 | -0.23 | 0.20424 | miRanda | -0.12 | 0.0273 | NA | |
46 | hsa-miR-361-5p | ARHGAP31 | 0.97 | 0 | -1.16 | 2.0E-5 | mirMAP | -0.6 | 0 | NA | |
47 | hsa-miR-361-5p | ARHGAP6 | 0.97 | 0 | -3.25 | 0 | PITA; miRanda | -0.36 | 0.0112 | NA | |
48 | hsa-miR-361-5p | ARHGAP9 | 0.97 | 0 | -0.84 | 0.05605 | miRanda | -0.92 | 0 | NA | |
49 | hsa-miR-361-5p | ARHGEF37 | 0.97 | 0 | -1.85 | 0 | miRanda; miRNATAP | -0.68 | 0 | NA | |
50 | hsa-miR-361-5p | ARHGEF6 | 0.97 | 0 | -1.32 | 0 | miRanda | -0.26 | 0.0017 | NA | |
51 | hsa-miR-361-5p | ARL10 | 0.97 | 0 | -1.12 | 0.00198 | mirMAP | -0.31 | 0.00375 | NA | |
52 | hsa-miR-361-5p | ARL4C | 0.97 | 0 | -0.28 | 0.33535 | miRanda | -0.52 | 0 | NA | |
53 | hsa-miR-361-5p | ARMC4 | 0.97 | 0 | -3.15 | 0 | miRNATAP | -0.92 | 0 | NA | |
54 | hsa-miR-361-5p | ARNTL | 0.97 | 0 | -0.36 | 0.08956 | miRanda | -0.27 | 1.0E-5 | NA | |
55 | hsa-miR-361-5p | ARRB1 | 0.97 | 0 | -1.05 | 0.00043 | MirTarget; miRanda | -0.2 | 0.02241 | NA | |
56 | hsa-miR-361-5p | ARRDC3 | 0.97 | 0 | -0.71 | 0.00062 | MirTarget; PITA; miRanda; miRNATAP | -0.23 | 9.0E-5 | NA | |
57 | hsa-miR-361-5p | ARSB | 0.97 | 0 | -0.58 | 0.00052 | miRanda | -0.37 | 0 | NA | |
58 | hsa-miR-361-5p | ART3 | 0.97 | 0 | -1.79 | 0.00034 | miRanda | -0.72 | 0 | NA | |
59 | hsa-miR-361-5p | ASXL3 | 0.97 | 0 | -3.34 | 0 | mirMAP | -0.51 | 0.00129 | NA | |
60 | hsa-miR-361-5p | ATAD1 | 0.97 | 0 | -0.13 | 0.38155 | miRanda | -0.12 | 0.00433 | NA | |
61 | hsa-miR-361-5p | ATF3 | 0.97 | 0 | -3.23 | 0 | miRanda | -0.69 | 0 | NA | |
62 | hsa-miR-361-5p | ATF7 | 0.97 | 0 | -0.44 | 0.0002 | mirMAP | -0.13 | 0.00017 | NA | |
63 | hsa-miR-361-5p | ATL3 | 0.97 | 0 | -0.19 | 0.4343 | mirMAP | -0.25 | 0.0003 | NA | |
64 | hsa-miR-361-5p | ATP8B4 | 0.97 | 0 | -1.9 | 0 | miRanda | -0.93 | 0 | NA | |
65 | hsa-miR-361-5p | AXL | 0.97 | 0 | -1.77 | 0 | miRanda | -1.02 | 0 | NA | |
66 | hsa-miR-361-5p | B2M | 0.97 | 0 | -0 | 0.98848 | miRanda | -0.42 | 0 | NA | |
67 | hsa-miR-361-5p | BACH1 | 0.97 | 0 | -0.27 | 0.16316 | miRanda; mirMAP | -0.2 | 0.00029 | NA | |
68 | hsa-miR-361-5p | BASP1 | 0.97 | 0 | -0.12 | 0.79725 | miRanda | -0.26 | 0.04722 | NA | |
69 | hsa-miR-361-5p | BBX | 0.97 | 0 | -0.51 | 0.00131 | PITA; miRanda; mirMAP | -0.12 | 0.00704 | NA | |
70 | hsa-miR-361-5p | BCO2 | 0.97 | 0 | -2.28 | 0 | miRanda | -0.31 | 0.00644 | NA | |
71 | hsa-miR-361-5p | BDNF | 0.97 | 0 | -2.91 | 0 | PITA; miRanda; miRNATAP | -0.55 | 2.0E-5 | NA | |
72 | hsa-miR-361-5p | BEND4 | 0.97 | 0 | -1.97 | 7.0E-5 | mirMAP | -0.37 | 0.01166 | NA | |
73 | hsa-miR-361-5p | BEND6 | 0.97 | 0 | -0.8 | 0.03128 | miRanda | -0.46 | 2.0E-5 | NA | |
74 | hsa-miR-361-5p | BIRC7 | 0.97 | 0 | 0.81 | 0.12357 | miRanda | -0.76 | 0 | NA | |
75 | hsa-miR-361-5p | BMP2K | 0.97 | 0 | -0.34 | 0.13703 | miRanda | -0.18 | 0.00655 | NA | |
76 | hsa-miR-361-5p | BMPR2 | 0.97 | 0 | -0.59 | 4.0E-5 | MirTarget; miRanda; mirMAP; miRNATAP | -0.24 | 0 | NA | |
77 | hsa-miR-361-5p | BRMS1L | 0.97 | 0 | -0.51 | 0.00391 | miRanda | -0.14 | 0.00562 | NA | |
78 | hsa-miR-361-5p | BTG1 | 0.97 | 0 | -0.8 | 2.0E-5 | miRanda | -0.23 | 2.0E-5 | NA | |
79 | hsa-miR-361-5p | BTLA | 0.97 | 0 | -1.31 | 0.00559 | miRanda | -0.91 | 0 | NA | |
80 | hsa-miR-361-5p | C1orf21 | 0.97 | 0 | -1.51 | 0 | mirMAP | -0.16 | 0.02113 | NA | |
81 | hsa-miR-361-5p | C2CD4A | 0.97 | 0 | 0.55 | 0.29831 | miRanda | -0.37 | 0.01668 | NA | |
82 | hsa-miR-361-5p | C4BPB | 0.97 | 0 | -0.9 | 0.15563 | miRanda | -0.38 | 0.03846 | NA | |
83 | hsa-miR-361-5p | CACNB2 | 0.97 | 0 | -2.97 | 0 | miRanda | -0.74 | 0 | NA | |
84 | hsa-miR-361-5p | CACNB4 | 0.97 | 0 | -2.87 | 0 | miRanda; mirMAP | -0.67 | 0 | NA | |
85 | hsa-miR-361-5p | CALCOCO1 | 0.97 | 0 | -1.07 | 0 | miRanda | -0.14 | 0.00122 | NA | |
86 | hsa-miR-361-5p | CALCOCO2 | 0.97 | 0 | -0.5 | 1.0E-5 | miRNAWalker2 validate; miRanda | -0.17 | 0 | NA | |
87 | hsa-miR-361-5p | CALCRL | 0.97 | 0 | -0.67 | 0.01537 | MirTarget; PITA; miRanda; miRNATAP | -0.44 | 0 | NA | |
88 | hsa-miR-361-5p | CALD1 | 0.97 | 0 | -2.47 | 0 | miRanda; miRNATAP | -1.21 | 0 | NA | |
89 | hsa-miR-361-5p | CALHM2 | 0.97 | 0 | -0.53 | 0.01372 | miRanda | -0.24 | 0.0001 | NA | |
90 | hsa-miR-361-5p | CAPN6 | 0.97 | 0 | -3.48 | 0 | PITA; miRanda; miRNATAP | -0.55 | 0.00774 | NA | |
91 | hsa-miR-361-5p | CASP1 | 0.97 | 0 | -0.39 | 0.33513 | miRanda | -0.55 | 0 | NA | |
92 | hsa-miR-361-5p | CASP4 | 0.97 | 0 | 0.1 | 0.69047 | miRanda | -0.25 | 0.00033 | NA | |
93 | hsa-miR-361-5p | CAV1 | 0.97 | 0 | -2.02 | 0 | miRanda | -1 | 0 | NA | |
94 | hsa-miR-361-5p | CAV2 | 0.97 | 0 | -0.86 | 0.01061 | miRanda | -0.63 | 0 | NA | |
95 | hsa-miR-361-5p | CBLN1 | 0.97 | 0 | -3.04 | 0 | miRanda | -0.69 | 2.0E-5 | NA | |
96 | hsa-miR-361-5p | CBX6 | 0.97 | 0 | -1.54 | 0 | mirMAP | -0.19 | 0.03211 | NA | |
97 | hsa-miR-361-5p | CCDC152 | 0.97 | 0 | -1.86 | 0 | miRanda | -0.44 | 0.00014 | NA | |
98 | hsa-miR-361-5p | CCDC6 | 0.97 | 0 | -0.27 | 0.05122 | miRanda | -0.24 | 0 | NA | |
99 | hsa-miR-361-5p | CCDC88A | 0.97 | 0 | -0.76 | 0.01199 | miRanda | -0.35 | 6.0E-5 | NA | |
100 | hsa-miR-361-5p | CCDC88B | 0.97 | 0 | 0.26 | 0.37339 | miRanda | -0.19 | 0.0307 | NA | |
101 | hsa-miR-361-5p | CCDC91 | 0.97 | 0 | -0.41 | 0.01203 | miRanda | -0.16 | 0.00078 | NA | |
102 | hsa-miR-361-5p | CCNYL1 | 0.97 | 0 | -0.16 | 0.40711 | MirTarget; miRanda; miRNATAP | -0.16 | 0.00312 | NA | |
103 | hsa-miR-361-5p | CCR6 | 0.97 | 0 | -1.12 | 0.00057 | miRanda | -0.48 | 0 | NA | |
104 | hsa-miR-361-5p | CD109 | 0.97 | 0 | -0.51 | 0.31559 | miRanda | -0.95 | 0 | NA | |
105 | hsa-miR-361-5p | CD177 | 0.97 | 0 | -0.07 | 0.91649 | miRanda; miRNATAP | -0.73 | 6.0E-5 | NA | |
106 | hsa-miR-361-5p | CD36 | 0.97 | 0 | -1.94 | 0.00141 | miRanda | -0.56 | 0.00146 | NA | |
107 | hsa-miR-361-5p | CD40 | 0.97 | 0 | -0.38 | 0.28617 | miRanda | -0.33 | 0.00151 | NA | |
108 | hsa-miR-361-5p | CD48 | 0.97 | 0 | -1.58 | 0.00055 | miRanda | -0.98 | 0 | NA | |
109 | hsa-miR-361-5p | CD84 | 0.97 | 0 | -0.53 | 0.27947 | mirMAP | -1.08 | 0 | NA | |
110 | hsa-miR-361-5p | CDADC1 | 0.97 | 0 | -0.5 | 0.00184 | miRanda | -0.15 | 0.00124 | NA | |
111 | hsa-miR-361-5p | CDC42BPA | 0.97 | 0 | -1.41 | 0 | miRanda | -0.36 | 0 | NA | |
112 | hsa-miR-361-5p | CDH2 | 0.97 | 0 | -0.37 | 0.51007 | miRanda | -0.9 | 0 | NA | |
113 | hsa-miR-361-5p | CDK17 | 0.97 | 0 | -0.52 | 0.00027 | miRanda | -0.15 | 0.00039 | NA | |
114 | hsa-miR-361-5p | CEACAM21 | 0.97 | 0 | -0.15 | 0.72613 | miRanda | -0.84 | 0 | NA | |
115 | hsa-miR-361-5p | CELF2 | 0.97 | 0 | -3.05 | 0 | miRNATAP | -1.27 | 0 | NA | |
116 | hsa-miR-361-5p | CFL2 | 0.97 | 0 | -2.62 | 0 | miRanda | -0.81 | 0 | NA | |
117 | hsa-miR-361-5p | CGRRF1 | 0.97 | 0 | -0.82 | 0 | miRanda | -0.1 | 0.005 | NA | |
118 | hsa-miR-361-5p | CH25H | 0.97 | 0 | -3 | 0 | miRanda | -1.01 | 0 | NA | |
119 | hsa-miR-361-5p | CHD9 | 0.97 | 0 | -0.8 | 1.0E-5 | PITA; miRanda | -0.13 | 0.01508 | NA | |
120 | hsa-miR-361-5p | CHST11 | 0.97 | 0 | 0.54 | 0.2311 | miRanda | -0.85 | 0 | NA | |
121 | hsa-miR-361-5p | CISD1 | 0.97 | 0 | -0.39 | 0.01804 | miRNATAP | -0.36 | 0 | NA | |
122 | hsa-miR-361-5p | CISH | 0.97 | 0 | 0.07 | 0.77166 | miRanda | -0.19 | 0.00414 | NA | |
123 | hsa-miR-361-5p | CLDN11 | 0.97 | 0 | -2.16 | 0 | miRanda | -0.33 | 0.01695 | NA | |
124 | hsa-miR-361-5p | CLEC1A | 0.97 | 0 | -1.37 | 0 | miRanda | -0.53 | 0 | NA | |
125 | hsa-miR-361-5p | CLEC3A | 0.97 | 0 | -5.97 | 0 | miRanda | -1.71 | 0 | NA | |
126 | hsa-miR-361-5p | CLEC4E | 0.97 | 0 | -1.11 | 0.05437 | miRanda | -1.33 | 0 | NA | |
127 | hsa-miR-361-5p | CLEC4GP1 | 0.97 | 0 | -1.23 | 0.02196 | miRanda | -0.64 | 4.0E-5 | NA | |
128 | hsa-miR-361-5p | CLEC7A | 0.97 | 0 | 0.76 | 0.08786 | miRanda | -0.62 | 0 | NA | |
129 | hsa-miR-361-5p | CLIC2 | 0.97 | 0 | -1.44 | 0 | PITA; miRanda; miRNATAP | -0.53 | 0 | NA | |
130 | hsa-miR-361-5p | CLIC4 | 0.97 | 0 | -1.72 | 0 | miRanda | -0.82 | 0 | NA | |
131 | hsa-miR-361-5p | CLIP4 | 0.97 | 0 | -1.61 | 0 | miRanda | -0.63 | 0 | NA | |
132 | hsa-miR-361-5p | CLN5 | 0.97 | 0 | -0.32 | 0.02528 | miRanda | -0.15 | 0.00042 | NA | |
133 | hsa-miR-361-5p | CLU | 0.97 | 0 | -2.85 | 0 | miRanda | -0.95 | 0 | NA | |
134 | hsa-miR-361-5p | CMPK2 | 0.97 | 0 | 1.23 | 0.00022 | miRanda | -0.19 | 0.04534 | NA | |
135 | hsa-miR-361-5p | CNRIP1 | 0.97 | 0 | -2.41 | 0 | miRanda | -0.83 | 0 | NA | |
136 | hsa-miR-361-5p | CNTLN | 0.97 | 0 | -1.17 | 0.00322 | miRanda | -0.42 | 0.00031 | NA | |
137 | hsa-miR-361-5p | COBL | 0.97 | 0 | -2.83 | 2.0E-5 | miRanda | -0.44 | 0.02337 | NA | |
138 | hsa-miR-361-5p | COL11A1 | 0.97 | 0 | 4.69 | 0 | miRanda; miRNATAP | -0.97 | 7.0E-5 | NA | |
139 | hsa-miR-361-5p | COL14A1 | 0.97 | 0 | -3.66 | 0 | miRanda | -1.07 | 0 | NA | |
140 | hsa-miR-361-5p | COL15A1 | 0.97 | 0 | -0.94 | 0.00988 | miRanda | -0.9 | 0 | NA | |
141 | hsa-miR-361-5p | COL4A4 | 0.97 | 0 | -2.67 | 0 | MirTarget; miRanda | -0.6 | 1.0E-5 | NA | |
142 | hsa-miR-361-5p | CORIN | 0.97 | 0 | -0.97 | 0.01159 | miRanda | -0.41 | 0.00027 | NA | |
143 | hsa-miR-361-5p | CORO1C | 0.97 | 0 | -1.12 | 0 | miRanda | -0.49 | 0 | NA | |
144 | hsa-miR-361-5p | CPT1A | 0.97 | 0 | -0.83 | 0.00093 | miRanda | -0.25 | 0.00051 | NA | |
145 | hsa-miR-361-5p | CR1 | 0.97 | 0 | -1.99 | 0.00029 | MirTarget; miRanda | -1.22 | 0 | NA | |
146 | hsa-miR-361-5p | CREB3L2 | 0.97 | 0 | -0.29 | 0.1662 | miRanda | -0.16 | 0.01127 | NA | |
147 | hsa-miR-361-5p | CREB5 | 0.97 | 0 | -2.28 | 0 | PITA; miRNATAP | -0.75 | 0 | NA | |
148 | hsa-miR-361-5p | CREG1 | 0.97 | 0 | -0.22 | 0.23382 | MirTarget; miRanda | -0.15 | 0.00691 | NA | |
149 | hsa-miR-361-5p | CSF2RA | 0.97 | 0 | -0.46 | 0.33646 | miRanda | -0.99 | 0 | NA | |
150 | hsa-miR-361-5p | CSF3R | 0.97 | 0 | -0.24 | 0.56343 | miRanda | -0.59 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 154 | 1848 | 4.102e-21 | 1.909e-17 |
2 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 125 | 1395 | 1.333e-19 | 3.101e-16 |
3 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 137 | 1656 | 1.936e-18 | 2.777e-15 |
4 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 86 | 799 | 2.387e-18 | 2.777e-15 |
5 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 121 | 1381 | 3.376e-18 | 3.141e-15 |
6 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 137 | 1672 | 4.416e-18 | 3.425e-15 |
7 | REGULATION OF CELL DIFFERENTIATION | 125 | 1492 | 3.052e-17 | 2.029e-14 |
8 | POSITIVE REGULATION OF CELL COMMUNICATION | 124 | 1532 | 5.983e-16 | 3.48e-13 |
9 | RESPONSE TO ENDOGENOUS STIMULUS | 119 | 1450 | 9.394e-16 | 4.857e-13 |
10 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 143 | 1929 | 3.689e-15 | 1.716e-12 |
11 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 92 | 1008 | 5.323e-15 | 2.251e-12 |
12 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 112 | 1360 | 6.003e-15 | 2.328e-12 |
13 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 77 | 771 | 1.001e-14 | 3.581e-12 |
14 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 99 | 1142 | 1.177e-14 | 3.911e-12 |
15 | NEUROGENESIS | 112 | 1402 | 4.795e-14 | 1.488e-11 |
16 | CELL MOTILITY | 79 | 835 | 8.152e-14 | 2.231e-11 |
17 | LOCALIZATION OF CELL | 79 | 835 | 8.152e-14 | 2.231e-11 |
18 | REGULATION OF CELL DEVELOPMENT | 79 | 836 | 8.688e-14 | 2.246e-11 |
19 | LOCOMOTION | 95 | 1114 | 1.165e-13 | 2.853e-11 |
20 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 87 | 983 | 1.817e-13 | 4.228e-11 |
21 | RESPONSE TO WOUNDING | 61 | 563 | 2.068e-13 | 4.582e-11 |
22 | BLOOD VESSEL MORPHOGENESIS | 47 | 364 | 2.561e-13 | 5.416e-11 |
23 | VASCULATURE DEVELOPMENT | 54 | 469 | 4.702e-13 | 9.513e-11 |
24 | INTRACELLULAR SIGNAL TRANSDUCTION | 118 | 1572 | 6.669e-13 | 1.266e-10 |
25 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 68 | 689 | 7.074e-13 | 1.266e-10 |
26 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 102 | 1275 | 7.059e-13 | 1.266e-10 |
27 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 74 | 788 | 7.703e-13 | 1.28e-10 |
28 | CIRCULATORY SYSTEM DEVELOPMENT | 74 | 788 | 7.703e-13 | 1.28e-10 |
29 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 129 | 1791 | 8.984e-13 | 1.441e-10 |
30 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 120 | 1618 | 9.309e-13 | 1.444e-10 |
31 | NEGATIVE REGULATION OF CELL COMMUNICATION | 97 | 1192 | 1.031e-12 | 1.548e-10 |
32 | REGULATION OF CELL PROLIFERATION | 113 | 1496 | 1.498e-12 | 2.178e-10 |
33 | WOUND HEALING | 53 | 470 | 1.772e-12 | 2.498e-10 |
34 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 78 | 876 | 2.686e-12 | 3.675e-10 |
35 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 87 | 1036 | 3.265e-12 | 4.22e-10 |
36 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 87 | 1036 | 3.265e-12 | 4.22e-10 |
37 | REGULATION OF MAPK CASCADE | 64 | 660 | 7.564e-12 | 9.512e-10 |
38 | REGULATION OF PROTEIN MODIFICATION PROCESS | 122 | 1710 | 8.011e-12 | 9.81e-10 |
39 | CELL DEVELOPMENT | 107 | 1426 | 9.711e-12 | 1.159e-09 |
40 | ANGIOGENESIS | 39 | 293 | 1.117e-11 | 1.299e-09 |
41 | RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 41 | 321 | 1.253e-11 | 1.422e-09 |
42 | RESPONSE TO LIPID | 77 | 888 | 1.382e-11 | 1.531e-09 |
43 | TISSUE DEVELOPMENT | 111 | 1518 | 1.863e-11 | 2.016e-09 |
44 | POSITIVE REGULATION OF MAPK CASCADE | 51 | 470 | 1.982e-11 | 2.096e-09 |
45 | CELLULAR RESPONSE TO LIPID | 50 | 457 | 2.328e-11 | 2.407e-09 |
46 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 90 | 1135 | 3.025e-11 | 3.06e-09 |
47 | RESPONSE TO NITROGEN COMPOUND | 74 | 859 | 4.842e-11 | 4.793e-09 |
48 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 52 | 498 | 5.239e-11 | 5.079e-09 |
49 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 83 | 1021 | 5.617e-11 | 5.333e-09 |
50 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 71 | 823 | 1.154e-10 | 1.074e-08 |
51 | REGULATION OF TRANSPORT | 123 | 1804 | 1.255e-10 | 1.145e-08 |
52 | REGULATION OF ION TRANSPORT | 57 | 592 | 1.47e-10 | 1.315e-08 |
53 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 69 | 801 | 2.29e-10 | 2.011e-08 |
54 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 66 | 750 | 2.376e-10 | 2.047e-08 |
55 | REGULATION OF METAL ION TRANSPORT | 39 | 325 | 2.619e-10 | 2.216e-08 |
56 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 51 | 505 | 2.667e-10 | 2.216e-08 |
57 | HOMEOSTATIC PROCESS | 98 | 1337 | 2.957e-10 | 2.373e-08 |
58 | RESPONSE TO GROWTH FACTOR | 49 | 475 | 2.917e-10 | 2.373e-08 |
59 | CELLULAR RESPONSE TO BIOTIC STIMULUS | 26 | 163 | 6.252e-10 | 4.931e-08 |
60 | CIRCULATORY SYSTEM PROCESS | 41 | 366 | 7.483e-10 | 5.803e-08 |
61 | REGULATION OF NEURON DIFFERENTIATION | 53 | 554 | 8.367e-10 | 6.382e-08 |
62 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 35 | 285 | 1.174e-09 | 8.813e-08 |
63 | BIOLOGICAL ADHESION | 80 | 1032 | 1.216e-09 | 8.981e-08 |
64 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 105 | 1518 | 1.642e-09 | 1.194e-07 |
65 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 43 | 408 | 1.912e-09 | 1.369e-07 |
66 | POSITIVE REGULATION OF TRANSPORT | 74 | 936 | 2.297e-09 | 1.62e-07 |
67 | REGULATION OF KINASE ACTIVITY | 65 | 776 | 2.432e-09 | 1.689e-07 |
68 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 103 | 1492 | 2.671e-09 | 1.827e-07 |
69 | POSITIVE REGULATION OF CELL PROLIFERATION | 67 | 814 | 2.779e-09 | 1.874e-07 |
70 | REGULATION OF CELL PROJECTION ORGANIZATION | 52 | 558 | 3.013e-09 | 2.002e-07 |
71 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 85 | 1152 | 3.759e-09 | 2.433e-07 |
72 | NEURON DIFFERENTIATION | 70 | 874 | 3.765e-09 | 2.433e-07 |
73 | POSITIVE REGULATION OF CELL DEVELOPMENT | 46 | 472 | 6.315e-09 | 4.025e-07 |
74 | PROTEIN PHOSPHORYLATION | 73 | 944 | 7.584e-09 | 4.769e-07 |
75 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 54 | 609 | 8.476e-09 | 5.258e-07 |
76 | CHEMICAL HOMEOSTASIS | 69 | 874 | 8.79e-09 | 5.312e-07 |
77 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 37 | 337 | 8.759e-09 | 5.312e-07 |
78 | REGULATION OF RESPONSE TO STRESS | 100 | 1468 | 9.358e-09 | 5.582e-07 |
79 | RESPONSE TO BACTERIUM | 49 | 528 | 9.957e-09 | 5.864e-07 |
80 | REGULATION OF CELL DEATH | 100 | 1472 | 1.075e-08 | 6.253e-07 |
81 | POSITIVE REGULATION OF KINASE ACTIVITY | 46 | 482 | 1.21e-08 | 6.953e-07 |
82 | POSITIVE REGULATION OF LOCOMOTION | 42 | 420 | 1.387e-08 | 7.869e-07 |
83 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 43 | 437 | 1.499e-08 | 8.403e-07 |
84 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 124 | 1977 | 1.712e-08 | 9.486e-07 |
85 | RESPONSE TO EXTERNAL STIMULUS | 116 | 1821 | 2.33e-08 | 1.276e-06 |
86 | REGULATION OF IMMUNE SYSTEM PROCESS | 95 | 1403 | 3.083e-08 | 1.668e-06 |
87 | IMMUNE SYSTEM PROCESS | 123 | 1984 | 3.839e-08 | 2.053e-06 |
88 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 42 | 437 | 4.317e-08 | 2.283e-06 |
89 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 113 | 1784 | 4.951e-08 | 2.588e-06 |
90 | REGULATION OF TRANSMEMBRANE TRANSPORT | 41 | 426 | 6.023e-08 | 3.114e-06 |
91 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 71 | 957 | 6.48e-08 | 3.277e-06 |
92 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 21 | 138 | 6.426e-08 | 3.277e-06 |
93 | REGULATION OF RESPONSE TO WOUNDING | 40 | 413 | 7.372e-08 | 3.688e-06 |
94 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 33 | 306 | 8.567e-08 | 4.241e-06 |
95 | CONNECTIVE TISSUE DEVELOPMENT | 25 | 194 | 1.08e-07 | 5.291e-06 |
96 | REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 26 | 208 | 1.12e-07 | 5.431e-06 |
97 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 43 | 470 | 1.21e-07 | 5.807e-06 |
98 | SKELETAL SYSTEM DEVELOPMENT | 42 | 455 | 1.331e-07 | 6.319e-06 |
99 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 67 | 905 | 1.683e-07 | 7.908e-06 |
100 | CYCLIC NUCLEOTIDE METABOLIC PROCESS | 13 | 57 | 1.723e-07 | 8.019e-06 |
101 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 68 | 926 | 1.833e-07 | 8.442e-06 |
102 | NEURON DEVELOPMENT | 55 | 687 | 1.934e-07 | 8.693e-06 |
103 | CARTILAGE DEVELOPMENT | 21 | 147 | 1.943e-07 | 8.693e-06 |
104 | REGULATION OF ORGAN MORPHOGENESIS | 28 | 242 | 1.907e-07 | 8.693e-06 |
105 | CELL PROLIFERATION | 54 | 672 | 2.225e-07 | 9.861e-06 |
106 | REGULATION OF MAP KINASE ACTIVITY | 33 | 319 | 2.278e-07 | 9.998e-06 |
107 | POSITIVE REGULATION OF GENE EXPRESSION | 108 | 1733 | 2.322e-07 | 1.01e-05 |
108 | TUBE DEVELOPMENT | 47 | 552 | 2.657e-07 | 1.134e-05 |
109 | REGULATION OF CELL MORPHOGENESIS | 47 | 552 | 2.657e-07 | 1.134e-05 |
110 | CELL CELL SIGNALING | 59 | 767 | 2.682e-07 | 1.134e-05 |
111 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 27 | 232 | 2.795e-07 | 1.172e-05 |
112 | RESPONSE TO CYTOKINE | 56 | 714 | 2.92e-07 | 1.213e-05 |
113 | NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 17 | 102 | 3.019e-07 | 1.243e-05 |
114 | RESPONSE TO PEPTIDE | 38 | 404 | 3.294e-07 | 1.333e-05 |
115 | CHONDROCYTE DIFFERENTIATION | 13 | 60 | 3.272e-07 | 1.333e-05 |
116 | NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 36 | 372 | 3.38e-07 | 1.356e-05 |
117 | ACTIVATION OF PROTEIN KINASE ACTIVITY | 30 | 279 | 3.516e-07 | 1.398e-05 |
118 | RESPONSE TO BIOTIC STIMULUS | 65 | 886 | 3.588e-07 | 1.415e-05 |
119 | REGULATION OF SYSTEM PROCESS | 44 | 507 | 3.806e-07 | 1.488e-05 |
120 | HEMOSTASIS | 32 | 311 | 3.912e-07 | 1.517e-05 |
121 | POSITIVE REGULATION OF ION TRANSPORT | 27 | 236 | 3.946e-07 | 1.517e-05 |
122 | NEGATIVE REGULATION OF CELL DEATH | 64 | 872 | 4.368e-07 | 1.666e-05 |
123 | REGULATION OF CYTOKINE PRODUCTION | 47 | 563 | 4.694e-07 | 1.776e-05 |
124 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 66 | 917 | 5.738e-07 | 2.153e-05 |
125 | REGULATION OF TRANSPORTER ACTIVITY | 24 | 198 | 6.06e-07 | 2.252e-05 |
126 | DEVELOPMENTAL GROWTH | 33 | 333 | 6.1e-07 | 2.252e-05 |
127 | MUSCLE STRUCTURE DEVELOPMENT | 39 | 432 | 6.573e-07 | 2.408e-05 |
128 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 31 | 303 | 6.712e-07 | 2.44e-05 |
129 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 13 | 64 | 7.226e-07 | 2.583e-05 |
130 | PEPTIDYL TYROSINE MODIFICATION | 23 | 186 | 7.272e-07 | 2.583e-05 |
131 | EXTRACELLULAR STRUCTURE ORGANIZATION | 31 | 304 | 7.208e-07 | 2.583e-05 |
132 | LEUKOCYTE MIGRATION | 28 | 259 | 7.711e-07 | 2.698e-05 |
133 | REGULATION OF SECRETION | 54 | 699 | 7.656e-07 | 2.698e-05 |
134 | NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 9 | 29 | 8.318e-07 | 2.867e-05 |
135 | REGULATION OF TRANSFERASE ACTIVITY | 67 | 946 | 8.31e-07 | 2.867e-05 |
136 | POSITIVE REGULATION OF CYTOKINE PRODUCTION | 35 | 370 | 8.396e-07 | 2.873e-05 |
137 | REGULATION OF BODY FLUID LEVELS | 43 | 506 | 9.065e-07 | 3.028e-05 |
138 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 45 | 541 | 9.112e-07 | 3.028e-05 |
139 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 37 | 404 | 8.998e-07 | 3.028e-05 |
140 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 45 | 541 | 9.112e-07 | 3.028e-05 |
141 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 63 | 872 | 9.226e-07 | 3.044e-05 |
142 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 26 | 232 | 9.604e-07 | 3.147e-05 |
143 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 37 | 406 | 1.013e-06 | 3.282e-05 |
144 | PHOSPHORYLATION | 81 | 1228 | 1.016e-06 | 3.282e-05 |
145 | REGULATION OF GROWTH | 50 | 633 | 1.044e-06 | 3.349e-05 |
146 | LIPID LOCALIZATION | 28 | 264 | 1.133e-06 | 3.61e-05 |
147 | GROWTH | 37 | 410 | 1.282e-06 | 4.057e-05 |
148 | POSITIVE REGULATION OF ENDOCYTOSIS | 17 | 114 | 1.525e-06 | 4.762e-05 |
149 | BEHAVIOR | 43 | 516 | 1.518e-06 | 4.762e-05 |
150 | REGULATION OF ERK1 AND ERK2 CASCADE | 26 | 238 | 1.561e-06 | 4.841e-05 |
151 | CELLULAR RESPONSE TO HORMONE STIMULUS | 45 | 552 | 1.572e-06 | 4.844e-05 |
152 | REGULATION OF HYDROLASE ACTIVITY | 85 | 1327 | 1.769e-06 | 5.416e-05 |
153 | POSITIVE REGULATION OF PROTEIN SECRETION | 24 | 211 | 1.916e-06 | 5.827e-05 |
154 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 17 | 116 | 1.952e-06 | 5.899e-05 |
155 | REGULATION OF CELL ADHESION | 49 | 629 | 1.985e-06 | 5.958e-05 |
156 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 30 | 303 | 2.004e-06 | 5.977e-05 |
157 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 20 | 156 | 2.163e-06 | 6.409e-05 |
158 | POSITIVE REGULATION OF SECRETION | 34 | 370 | 2.305e-06 | 6.787e-05 |
159 | CELLULAR RESPONSE TO PEPTIDE | 28 | 274 | 2.365e-06 | 6.92e-05 |
160 | REGULATION OF LIPID STORAGE | 10 | 41 | 2.386e-06 | 6.94e-05 |
161 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 48 | 616 | 2.509e-06 | 7.25e-05 |
162 | REGULATION OF PROTEIN SECRETION | 35 | 389 | 2.647e-06 | 7.602e-05 |
163 | POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 21 | 172 | 2.691e-06 | 7.682e-05 |
164 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 56 | 767 | 2.76e-06 | 7.83e-05 |
165 | REGULATION OF ION HOMEOSTASIS | 23 | 201 | 2.818e-06 | 7.945e-05 |
166 | REGULATION OF LIPASE ACTIVITY | 14 | 83 | 2.869e-06 | 8.042e-05 |
167 | CELLULAR HOMEOSTASIS | 51 | 676 | 3.09e-06 | 8.608e-05 |
168 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 42 | 513 | 3.147e-06 | 8.716e-05 |
169 | SECOND MESSENGER MEDIATED SIGNALING | 20 | 160 | 3.214e-06 | 8.85e-05 |
170 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 68 | 1004 | 3.26e-06 | 8.922e-05 |
171 | REGULATION OF BLOOD CIRCULATION | 29 | 295 | 3.409e-06 | 9.276e-05 |
172 | POSITIVE REGULATION OF CYTOKINE SECRETION | 15 | 96 | 3.446e-06 | 9.323e-05 |
173 | TISSUE MORPHOGENESIS | 43 | 533 | 3.504e-06 | 9.424e-05 |
174 | NEGATIVE REGULATION OF IMMUNE RESPONSE | 17 | 121 | 3.532e-06 | 9.445e-05 |
175 | CAMP METABOLIC PROCESS | 9 | 34 | 3.669e-06 | 9.756e-05 |
176 | REGULATION OF HOMEOSTATIC PROCESS | 38 | 447 | 3.867e-06 | 0.0001022 |
177 | DEFENSE RESPONSE | 79 | 1231 | 3.938e-06 | 0.0001035 |
178 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 39 | 465 | 3.992e-06 | 0.0001044 |
179 | MUSCLE SYSTEM PROCESS | 28 | 282 | 4.135e-06 | 0.0001075 |
180 | REGULATION OF IMMUNE RESPONSE | 60 | 858 | 4.744e-06 | 0.000122 |
181 | SENSORY PERCEPTION OF PAIN | 13 | 75 | 4.729e-06 | 0.000122 |
182 | ION HOMEOSTASIS | 45 | 576 | 4.837e-06 | 0.0001237 |
183 | POSITIVE REGULATION OF GROWTH | 25 | 238 | 4.996e-06 | 0.000127 |
184 | POSITIVE REGULATION OF HEART GROWTH | 8 | 27 | 5.087e-06 | 0.0001286 |
185 | REGULATION OF CALCIUM ION TRANSPORT | 23 | 209 | 5.463e-06 | 0.0001374 |
186 | HEAD DEVELOPMENT | 52 | 709 | 5.546e-06 | 0.0001387 |
187 | NEURON PROJECTION DEVELOPMENT | 43 | 545 | 6.144e-06 | 0.0001521 |
188 | REGULATION OF SYNAPSE ORGANIZATION | 16 | 113 | 6.139e-06 | 0.0001521 |
189 | RESPONSE TO ABIOTIC STIMULUS | 68 | 1024 | 6.328e-06 | 0.0001558 |
190 | REGULATION OF CARDIAC MUSCLE CONTRACTION | 12 | 66 | 6.546e-06 | 0.00016 |
191 | REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 15 | 101 | 6.567e-06 | 0.00016 |
192 | REGULATION OF DEVELOPMENTAL GROWTH | 28 | 289 | 6.608e-06 | 0.0001601 |
193 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 19 | 154 | 6.827e-06 | 0.0001638 |
194 | NEGATIVE REGULATION OF TRANSPORT | 38 | 458 | 6.805e-06 | 0.0001638 |
195 | CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 10 | 46 | 7.299e-06 | 0.0001742 |
196 | POSITIVE REGULATION OF CELL DEATH | 46 | 605 | 7.723e-06 | 0.0001833 |
197 | REGULATION OF ENDOCYTOSIS | 22 | 199 | 8.074e-06 | 0.0001907 |
198 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 105 | 1805 | 8.128e-06 | 0.000191 |
199 | BONE DEVELOPMENT | 19 | 156 | 8.25e-06 | 0.000191 |
200 | RESPONSE TO HORMONE | 61 | 893 | 8.195e-06 | 0.000191 |
201 | REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 19 | 156 | 8.25e-06 | 0.000191 |
202 | REGULATION OF CELLULAR LOCALIZATION | 80 | 1277 | 8.311e-06 | 0.0001914 |
203 | SYSTEM PROCESS | 104 | 1785 | 8.441e-06 | 0.0001935 |
204 | REGULATION OF MEMBRANE POTENTIAL | 31 | 343 | 8.935e-06 | 0.0002038 |
205 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 15 | 104 | 9.47e-06 | 0.0002139 |
206 | REGULATION OF INTERLEUKIN 6 PRODUCTION | 15 | 104 | 9.47e-06 | 0.0002139 |
207 | REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 14 | 92 | 9.95e-06 | 0.0002226 |
208 | POSITIVE REGULATION OF ORGAN GROWTH | 9 | 38 | 9.943e-06 | 0.0002226 |
209 | REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 24 | 233 | 1.072e-05 | 0.0002387 |
210 | SYNAPSE ORGANIZATION | 18 | 145 | 1.087e-05 | 0.0002401 |
211 | REGULATION OF JNK CASCADE | 19 | 159 | 1.089e-05 | 0.0002401 |
212 | CELL DEATH | 66 | 1001 | 1.095e-05 | 0.0002403 |
213 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 7 | 22 | 1.191e-05 | 0.0002603 |
214 | REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 70 | 1.23e-05 | 0.0002674 |
215 | REGULATION OF PHOSPHOLIPASE C ACTIVITY | 9 | 39 | 1.249e-05 | 0.0002691 |
216 | MORPHOGENESIS OF AN EPITHELIUM | 34 | 400 | 1.244e-05 | 0.0002691 |
217 | REGULATION OF GTPASE ACTIVITY | 49 | 673 | 1.257e-05 | 0.0002696 |
218 | REGULATION OF CATABOLIC PROCESS | 52 | 731 | 1.298e-05 | 0.0002757 |
219 | MESENCHYME DEVELOPMENT | 21 | 190 | 1.294e-05 | 0.0002757 |
220 | SINGLE ORGANISM BEHAVIOR | 33 | 384 | 1.329e-05 | 0.0002798 |
221 | GLOMERULUS DEVELOPMENT | 10 | 49 | 1.327e-05 | 0.0002798 |
222 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 38 | 472 | 1.35e-05 | 0.000283 |
223 | CELL CHEMOTAXIS | 19 | 162 | 1.425e-05 | 0.0002961 |
224 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 19 | 162 | 1.425e-05 | 0.0002961 |
225 | POSITIVE REGULATION OF MAP KINASE ACTIVITY | 22 | 207 | 1.514e-05 | 0.0003131 |
226 | VASCULAR PROCESS IN CIRCULATORY SYSTEM | 19 | 163 | 1.557e-05 | 0.0003206 |
227 | REGULATION OF OSSIFICATION | 20 | 178 | 1.622e-05 | 0.0003324 |
228 | MEMBRANE DEPOLARIZATION | 11 | 61 | 1.718e-05 | 0.0003505 |
229 | CELLULAR RESPONSE TO CYTOKINE STIMULUS | 45 | 606 | 1.751e-05 | 0.0003554 |
230 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 6 | 16 | 1.757e-05 | 0.0003554 |
231 | NEURON MIGRATION | 15 | 110 | 1.888e-05 | 0.0003803 |
232 | IMMUNE RESPONSE | 70 | 1100 | 1.902e-05 | 0.0003815 |
233 | REGULATION OF EPITHELIAL CELL MIGRATION | 19 | 166 | 2.019e-05 | 0.0003998 |
234 | FOREBRAIN CELL MIGRATION | 11 | 62 | 2.017e-05 | 0.0003998 |
235 | CELLULAR COMPONENT MORPHOGENESIS | 60 | 900 | 2.013e-05 | 0.0003998 |
236 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 14 | 98 | 2.086e-05 | 0.0004112 |
237 | PROTEIN LOCALIZATION | 103 | 1805 | 2.234e-05 | 0.0004386 |
238 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 21 | 197 | 2.246e-05 | 0.0004391 |
239 | REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 22 | 213 | 2.368e-05 | 0.000461 |
240 | AMEBOIDAL TYPE CELL MIGRATION | 18 | 154 | 2.494e-05 | 0.0004835 |
241 | REGULATION OF INFLAMMATORY RESPONSE | 27 | 294 | 2.518e-05 | 0.0004862 |
242 | CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 6 | 17 | 2.627e-05 | 0.000503 |
243 | NEGATIVE REGULATION OF LIPID STORAGE | 6 | 17 | 2.627e-05 | 0.000503 |
244 | POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 10 | 53 | 2.742e-05 | 0.000523 |
245 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 15 | 114 | 2.906e-05 | 0.0005496 |
246 | CEREBRAL CORTEX CELL MIGRATION | 9 | 43 | 2.899e-05 | 0.0005496 |
247 | MEMBRANE ASSEMBLY | 7 | 25 | 3.038e-05 | 0.00057 |
248 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 7 | 25 | 3.038e-05 | 0.00057 |
249 | RHYTHMIC PROCESS | 27 | 298 | 3.195e-05 | 0.000597 |
250 | DEVELOPMENTAL CELL GROWTH | 12 | 77 | 3.328e-05 | 0.0006194 |
251 | COGNITION | 24 | 251 | 3.669e-05 | 0.0006774 |
252 | CELL ACTIVATION | 42 | 568 | 3.666e-05 | 0.0006774 |
253 | POSITIVE REGULATION OF LIPASE ACTIVITY | 11 | 66 | 3.71e-05 | 0.0006823 |
254 | NEGATIVE REGULATION OF PHOSPHORYLATION | 34 | 422 | 3.744e-05 | 0.0006859 |
255 | POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 16 | 131 | 4.05e-05 | 0.000739 |
256 | REGULATION OF HEART CONTRACTION | 22 | 221 | 4.173e-05 | 0.0007579 |
257 | STEM CELL DIFFERENTIATION | 20 | 190 | 4.188e-05 | 0.0007579 |
258 | MUSCLE CELL DIFFERENTIATION | 23 | 237 | 4.202e-05 | 0.0007579 |
259 | REGULATION OF STRIATED MUSCLE CONTRACTION | 12 | 79 | 4.325e-05 | 0.000777 |
260 | RESPONSE TO REACTIVE OXYGEN SPECIES | 20 | 191 | 4.514e-05 | 0.0008079 |
261 | REGULATION OF MUSCLE CONTRACTION | 17 | 147 | 4.765e-05 | 0.0008494 |
262 | POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 57 | 867 | 4.787e-05 | 0.0008501 |
263 | FOREBRAIN DEVELOPMENT | 30 | 357 | 4.922e-05 | 0.0008677 |
264 | POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 18 | 162 | 4.923e-05 | 0.0008677 |
265 | TUBE MORPHOGENESIS | 28 | 323 | 5.057e-05 | 0.0008879 |
266 | REGULATION OF PROTEIN LOCALIZATION | 61 | 950 | 5.139e-05 | 0.000899 |
267 | DEVELOPMENTAL MATURATION | 20 | 193 | 5.234e-05 | 0.0009122 |
268 | REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 10 | 57 | 5.292e-05 | 0.0009188 |
269 | MESENCHYMAL CELL DIFFERENTIATION | 16 | 134 | 5.35e-05 | 0.0009254 |
270 | GLOMERULAR EPITHELIUM DEVELOPMENT | 6 | 19 | 5.394e-05 | 0.0009295 |
271 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 25 | 274 | 5.528e-05 | 0.0009492 |
272 | REGULATION OF SEQUESTERING OF CALCIUM ION | 14 | 107 | 5.665e-05 | 0.0009656 |
273 | REGULATION OF CYTOKINE SECRETION | 17 | 149 | 5.66e-05 | 0.0009656 |
274 | CELL GROWTH | 16 | 135 | 5.858e-05 | 0.0009949 |
275 | ACTIN FILAMENT BASED PROCESS | 35 | 450 | 5.938e-05 | 0.001005 |
276 | REGULATION OF MUSCLE SYSTEM PROCESS | 20 | 195 | 6.055e-05 | 0.001021 |
277 | IMMUNE SYSTEM DEVELOPMENT | 42 | 582 | 6.377e-05 | 0.001071 |
278 | CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 11 | 70 | 6.507e-05 | 0.001089 |
279 | RESPONSE TO OXYGEN LEVELS | 27 | 311 | 6.677e-05 | 0.001114 |
280 | REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 7 | 28 | 6.771e-05 | 0.001125 |
281 | REGULATION OF DEFENSE RESPONSE | 51 | 759 | 6.942e-05 | 0.00115 |
282 | REGULATION OF ADAPTIVE IMMUNE RESPONSE | 15 | 123 | 7.116e-05 | 0.001171 |
283 | MULTI MULTICELLULAR ORGANISM PROCESS | 21 | 213 | 7.119e-05 | 0.001171 |
284 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 24 | 262 | 7.269e-05 | 0.001189 |
285 | REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 17 | 152 | 7.282e-05 | 0.001189 |
286 | RELAXATION OF MUSCLE | 6 | 20 | 7.457e-05 | 0.001213 |
287 | SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 8 | 38 | 7.722e-05 | 0.001252 |
288 | SECRETION | 42 | 588 | 8.02e-05 | 0.001282 |
289 | TISSUE MIGRATION | 12 | 84 | 8.017e-05 | 0.001282 |
290 | REGULATION OF AXONOGENESIS | 18 | 168 | 7.938e-05 | 0.001282 |
291 | POSITIVE REGULATION OF OSSIFICATION | 12 | 84 | 8.017e-05 | 0.001282 |
292 | POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT | 13 | 97 | 8.05e-05 | 0.001283 |
293 | AGING | 24 | 264 | 8.19e-05 | 0.001301 |
294 | REGULATION OF BLOOD PRESSURE | 18 | 169 | 8.574e-05 | 0.001357 |
295 | POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 9 | 49 | 8.605e-05 | 0.001357 |
296 | UROGENITAL SYSTEM DEVELOPMENT | 26 | 299 | 8.817e-05 | 0.001386 |
297 | SYNAPTIC SIGNALING | 33 | 424 | 9.45e-05 | 0.001476 |
298 | REGULATION OF IMMUNE EFFECTOR PROCESS | 33 | 424 | 9.45e-05 | 0.001476 |
299 | REGULATION OF ORGAN GROWTH | 11 | 73 | 9.645e-05 | 0.001501 |
300 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 12 | 86 | 0.0001012 | 0.00157 |
301 | NEGATIVE REGULATION OF ION TRANSPORT | 15 | 127 | 0.0001028 | 0.00159 |
302 | REGULATION OF NEURON DEATH | 23 | 252 | 0.0001078 | 0.00166 |
303 | MEMBRANE BIOGENESIS | 7 | 30 | 0.0001089 | 0.001673 |
304 | RESPONSE TO PURINE CONTAINING COMPOUND | 17 | 158 | 0.0001179 | 0.001805 |
305 | HEART DEVELOPMENT | 35 | 466 | 0.0001186 | 0.00181 |
306 | POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 5 | 14 | 0.0001205 | 0.001827 |
307 | CAMP CATABOLIC PROCESS | 5 | 14 | 0.0001205 | 0.001827 |
308 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 11 | 75 | 0.0001239 | 0.001872 |
309 | REGULATION OF CELL KILLING | 10 | 63 | 0.0001274 | 0.001919 |
310 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 25 | 289 | 0.0001299 | 0.00195 |
311 | POSITIVE REGULATION OF CATABOLIC PROCESS | 31 | 395 | 0.0001313 | 0.001965 |
312 | NEGATIVE REGULATION OF MUSCLE CONTRACTION | 6 | 22 | 0.0001345 | 0.001993 |
313 | CELLULAR RESPONSE TO ACID CHEMICAL | 18 | 175 | 0.0001342 | 0.001993 |
314 | HOMEOSTASIS OF NUMBER OF CELLS | 18 | 175 | 0.0001342 | 0.001993 |
315 | RENAL SYSTEM PROCESS | 13 | 102 | 0.0001356 | 0.002004 |
316 | RESPONSE TO FIBROBLAST GROWTH FACTOR | 14 | 116 | 0.0001375 | 0.002023 |
317 | ORGAN MORPHOGENESIS | 54 | 841 | 0.0001387 | 0.002023 |
318 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 9 | 52 | 0.0001391 | 0.002023 |
319 | CELL PROJECTION ORGANIZATION | 57 | 902 | 0.0001382 | 0.002023 |
320 | REGULATION OF LIPID CATABOLIC PROCESS | 9 | 52 | 0.0001391 | 0.002023 |
321 | DIVALENT INORGANIC CATION HOMEOSTASIS | 28 | 343 | 0.0001423 | 0.002062 |
322 | EPITHELIUM DEVELOPMENT | 59 | 945 | 0.0001461 | 0.002106 |
323 | LEARNING | 15 | 131 | 0.0001462 | 0.002106 |
324 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 103 | 0.0001499 | 0.002153 |
325 | NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 14 | 117 | 0.0001508 | 0.002159 |
326 | LEUKOCYTE DIFFERENTIATION | 25 | 292 | 0.0001527 | 0.00218 |
327 | ION TRANSPORT | 74 | 1262 | 0.0001542 | 0.002194 |
328 | REGULATION OF HEART GROWTH | 8 | 42 | 0.0001629 | 0.00231 |
329 | CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 13 | 104 | 0.0001654 | 0.00234 |
330 | REGULATION OF CHEMOKINE PRODUCTION | 10 | 65 | 0.0001666 | 0.00235 |
331 | SALIVARY GLAND DEVELOPMENT | 7 | 32 | 0.0001685 | 0.002361 |
332 | RESPONSE TO MECHANICAL STIMULUS | 20 | 210 | 0.0001682 | 0.002361 |
333 | POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 5 | 15 | 0.0001751 | 0.00244 |
334 | NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 5 | 15 | 0.0001751 | 0.00244 |
335 | CEREBRAL CORTEX DEVELOPMENT | 13 | 105 | 0.0001823 | 0.002533 |
336 | CELL SUBSTRATE ADHESION | 17 | 164 | 0.0001859 | 0.002574 |
337 | REGULATION OF CELLULAR RESPONSE TO STRESS | 46 | 691 | 0.0001931 | 0.002667 |
338 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 21 | 229 | 0.0001981 | 0.002719 |
339 | REGULATION OF DENDRITE DEVELOPMENT | 14 | 120 | 0.0001976 | 0.002719 |
340 | REGULATION OF SYNAPSE ASSEMBLY | 11 | 79 | 0.0001991 | 0.002724 |
341 | NEGATIVE REGULATION OF LOCOMOTION | 23 | 263 | 0.0002031 | 0.002771 |
342 | POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 7 | 33 | 0.0002069 | 0.002814 |
343 | CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 17 | 166 | 0.0002151 | 0.002918 |
344 | REGULATION OF VESICLE MEDIATED TRANSPORT | 34 | 462 | 0.0002166 | 0.002929 |
345 | RESPONSE TO OXIDATIVE STRESS | 28 | 352 | 0.000219 | 0.002954 |
346 | EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 6 | 24 | 0.0002272 | 0.003056 |
347 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 17 | 167 | 0.0002312 | 0.0031 |
348 | TAXIS | 34 | 464 | 0.0002346 | 0.003137 |
349 | POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 10 | 68 | 0.0002442 | 0.003256 |
350 | POSITIVE REGULATION OF HOMEOSTATIC PROCESS | 20 | 216 | 0.0002452 | 0.003259 |
351 | REGULATION OF FATTY ACID BETA OXIDATION | 5 | 16 | 0.0002468 | 0.003271 |
352 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 18 | 184 | 0.0002518 | 0.003329 |
353 | REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 153 | 0.0002573 | 0.003382 |
354 | PALLIUM DEVELOPMENT | 16 | 153 | 0.0002573 | 0.003382 |
355 | REGULATION OF INTRACELLULAR TRANSPORT | 42 | 621 | 0.0002609 | 0.00342 |
356 | POSITIVE REGULATION OF AXONOGENESIS | 10 | 69 | 0.000276 | 0.003607 |
357 | INOSITOL LIPID MEDIATED SIGNALING | 14 | 124 | 0.0002791 | 0.003637 |
358 | NEGATIVE REGULATION OF CELL PROLIFERATION | 43 | 643 | 0.0002814 | 0.003657 |
359 | ENDOTHELIAL CELL MIGRATION | 9 | 57 | 0.000287 | 0.00372 |
360 | REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 25 | 0.0002894 | 0.00374 |
361 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 19 | 203 | 0.0003028 | 0.003892 |
362 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 19 | 203 | 0.0003028 | 0.003892 |
363 | CYTOKINE MEDIATED SIGNALING PATHWAY | 33 | 452 | 0.0003078 | 0.003946 |
364 | REGULATION OF POTASSIUM ION TRANSPORT | 11 | 83 | 0.0003097 | 0.003959 |
365 | NEURAL PRECURSOR CELL PROLIFERATION | 10 | 70 | 0.0003111 | 0.003966 |
366 | REGULATION OF IMMUNOGLOBULIN SECRETION | 5 | 17 | 0.0003386 | 0.004282 |
367 | REGULATION OF PROTEIN KINASE A SIGNALING | 5 | 17 | 0.0003386 | 0.004282 |
368 | ACTIVATION OF PROTEIN KINASE A ACTIVITY | 5 | 17 | 0.0003386 | 0.004282 |
369 | CELLULAR CHEMICAL HOMEOSTASIS | 39 | 570 | 0.000341 | 0.0043 |
370 | FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 11 | 84 | 0.0003443 | 0.00433 |
371 | RESPONSE TO ALCOHOL | 28 | 362 | 0.0003456 | 0.004334 |
372 | POSITIVE REGULATION OF BINDING | 14 | 127 | 0.0003578 | 0.004475 |
373 | NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 8 | 47 | 0.0003667 | 0.00449 |
374 | NEGATIVE REGULATION OF BLOOD CIRCULATION | 7 | 36 | 0.0003659 | 0.00449 |
375 | CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 7 | 36 | 0.0003659 | 0.00449 |
376 | VASODILATION | 6 | 26 | 0.0003641 | 0.00449 |
377 | REGULATION OF SENSORY PERCEPTION | 7 | 36 | 0.0003659 | 0.00449 |
378 | NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 7 | 36 | 0.0003659 | 0.00449 |
379 | REGULATION OF AMINO ACID TRANSPORT | 6 | 26 | 0.0003641 | 0.00449 |
380 | REGULATION OF SENSORY PERCEPTION OF PAIN | 7 | 36 | 0.0003659 | 0.00449 |
381 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 36 | 514 | 0.0003693 | 0.004511 |
382 | NEGATIVE REGULATION OF CELL ADHESION | 20 | 223 | 0.0003725 | 0.004537 |
383 | VASCULOGENESIS | 9 | 59 | 0.0003745 | 0.00455 |
384 | REGULATION OF STEM CELL DIFFERENTIATION | 13 | 113 | 0.0003793 | 0.004596 |
385 | HEART PROCESS | 11 | 85 | 0.0003821 | 0.004617 |
386 | LIPID PHOSPHORYLATION | 12 | 99 | 0.0003895 | 0.004695 |
387 | NEURON PROJECTION MORPHOGENESIS | 30 | 402 | 0.0003956 | 0.004756 |
388 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 18 | 191 | 0.0003976 | 0.004768 |
389 | RESPONSE TO STEROID HORMONE | 35 | 497 | 0.0004011 | 0.004798 |
390 | SINGLE ORGANISM CELL ADHESION | 33 | 459 | 0.0004046 | 0.004828 |
391 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 15 | 144 | 0.0004137 | 0.004897 |
392 | NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 15 | 144 | 0.0004137 | 0.004897 |
393 | REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 15 | 144 | 0.0004137 | 0.004897 |
394 | REGULATION OF GLUCOSE IMPORT | 9 | 60 | 0.0004259 | 0.005017 |
395 | LEUKOCYTE HOMEOSTASIS | 9 | 60 | 0.0004259 | 0.005017 |
396 | MUSCLE ORGAN DEVELOPMENT | 23 | 277 | 0.0004273 | 0.005021 |
397 | NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 7 | 37 | 0.0004366 | 0.005104 |
398 | CARDIAC MUSCLE CELL ACTION POTENTIAL | 7 | 37 | 0.0004366 | 0.005104 |
399 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 278 | 0.0004495 | 0.005237 |
400 | NEPHRON DEVELOPMENT | 13 | 115 | 0.0004502 | 0.005237 |
401 | REGULATION OF CYTOPLASMIC TRANSPORT | 34 | 481 | 0.0004516 | 0.005241 |
402 | POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 5 | 18 | 0.0004542 | 0.005244 |
403 | ORGAN MATURATION | 5 | 18 | 0.0004542 | 0.005244 |
404 | TISSUE REMODELING | 11 | 87 | 0.0004681 | 0.005391 |
405 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 9 | 61 | 0.000483 | 0.005549 |
406 | PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 8 | 49 | 0.0004917 | 0.005622 |
407 | REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 19 | 211 | 0.0004916 | 0.005622 |
408 | COLLAGEN FIBRIL ORGANIZATION | 7 | 38 | 0.0005177 | 0.00589 |
409 | REGULATION OF CATION CHANNEL ACTIVITY | 11 | 88 | 0.0005169 | 0.00589 |
410 | POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING | 17 | 179 | 0.0005218 | 0.005922 |
411 | REGULATION OF RECEPTOR ACTIVITY | 13 | 117 | 0.0005321 | 0.006009 |
412 | LEUKOCYTE CHEMOTAXIS | 13 | 117 | 0.0005321 | 0.006009 |
413 | SECRETION BY CELL | 34 | 486 | 0.0005428 | 0.006115 |
414 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 9 | 62 | 0.0005462 | 0.006138 |
415 | RIBONUCLEOTIDE CATABOLIC PROCESS | 6 | 28 | 0.0005583 | 0.00623 |
416 | REGULATION OF CYTOKINE SECRETION INVOLVED IN IMMUNE RESPONSE | 4 | 11 | 0.0005623 | 0.00623 |
417 | REGULATION OF CHRONIC INFLAMMATORY RESPONSE | 4 | 11 | 0.0005623 | 0.00623 |
418 | MUSCLE HYPERTROPHY | 6 | 28 | 0.0005583 | 0.00623 |
419 | REGULATION OF FATTY ACID OXIDATION | 6 | 28 | 0.0005583 | 0.00623 |
420 | POSITIVE REGULATION OF NFAT PROTEIN IMPORT INTO NUCLEUS | 4 | 11 | 0.0005623 | 0.00623 |
421 | REGULATION OF ORGANIC ACID TRANSPORT | 8 | 50 | 0.0005661 | 0.006242 |
422 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 50 | 0.0005661 | 0.006242 |
423 | ANION TRANSPORT | 35 | 507 | 0.0005756 | 0.006332 |
424 | RESPONSE TO MUSCLE STRETCH | 5 | 19 | 0.0005972 | 0.006522 |
425 | REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 5 | 19 | 0.0005972 | 0.006522 |
426 | MUSCLE CELL CELLULAR HOMEOSTASIS | 5 | 19 | 0.0005972 | 0.006522 |
427 | POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 10 | 76 | 0.0006096 | 0.006636 |
428 | LONG TERM SYNAPTIC POTENTIATION | 7 | 39 | 0.0006104 | 0.006636 |
429 | LEUKOCYTE ACTIVATION | 30 | 414 | 0.0006416 | 0.006959 |
430 | NEURAL CREST CELL MIGRATION | 8 | 51 | 0.0006493 | 0.007026 |
431 | SINGLE ORGANISM CELLULAR LOCALIZATION | 54 | 898 | 0.0006775 | 0.007314 |
432 | ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 11 | 91 | 0.0006893 | 0.00739 |
433 | INFLAMMATORY RESPONSE | 32 | 454 | 0.000689 | 0.00739 |
434 | NEGATIVE REGULATION OF SECRETION | 18 | 200 | 0.0006883 | 0.00739 |
435 | LYMPHOCYTE ACTIVATION | 26 | 342 | 0.0007165 | 0.007647 |
436 | HINDBRAIN MORPHOGENESIS | 7 | 40 | 0.0007158 | 0.007647 |
437 | POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 12 | 106 | 0.0007277 | 0.00773 |
438 | TRANSITION METAL ION HOMEOSTASIS | 12 | 106 | 0.0007277 | 0.00773 |
439 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 14 | 137 | 0.000771 | 0.008171 |
440 | CELLULAR RESPONSE TO RETINOIC ACID | 9 | 65 | 0.0007774 | 0.008203 |
441 | REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 9 | 65 | 0.0007774 | 0.008203 |
442 | CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 4 | 12 | 0.0008181 | 0.008612 |
443 | DENDRITE DEVELOPMENT | 10 | 79 | 0.0008305 | 0.008723 |
444 | REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS | 8 | 53 | 0.0008451 | 0.008823 |
445 | RESPONSE TO INORGANIC SUBSTANCE | 33 | 479 | 0.0008457 | 0.008823 |
446 | REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 8 | 53 | 0.0008451 | 0.008823 |
447 | RESPONSE TO ORGANOPHOSPHORUS | 14 | 139 | 0.0008898 | 0.009262 |
448 | ACTION POTENTIAL | 11 | 94 | 0.000907 | 0.00942 |
449 | RESPONSE TO INSULIN | 18 | 205 | 0.0009176 | 0.009488 |
450 | INSULIN RECEPTOR SIGNALING PATHWAY | 10 | 80 | 0.0009173 | 0.009488 |
451 | MUSCLE TISSUE DEVELOPMENT | 22 | 275 | 0.0009254 | 0.009527 |
452 | MONOCARBOXYLIC ACID TRANSPORT | 13 | 124 | 0.0009245 | 0.009527 |
453 | RESPONSE TO HYDROGEN PEROXIDE | 12 | 109 | 0.000934 | 0.009594 |
454 | NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 8 | 54 | 0.0009595 | 0.009777 |
455 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 24 | 312 | 0.0009602 | 0.009777 |
456 | REGULATION OF SYNAPTIC PLASTICITY | 14 | 140 | 0.0009547 | 0.009777 |
457 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 15 | 156 | 0.0009581 | 0.009777 |
458 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 67 | 0.0009718 | 0.009873 |
459 | REGULATION OF RUFFLE ASSEMBLY | 5 | 21 | 0.0009808 | 0.0099 |
460 | CHONDROCYTE DEVELOPMENT | 5 | 21 | 0.0009808 | 0.0099 |
461 | NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 5 | 21 | 0.0009808 | 0.0099 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RECEPTOR BINDING | 102 | 1476 | 3.057e-09 | 2.84e-06 |
2 | PROTEIN DOMAIN SPECIFIC BINDING | 54 | 624 | 1.946e-08 | 9.038e-06 |
3 | KINASE BINDING | 48 | 606 | 1.592e-06 | 0.0003697 |
4 | LIPID BINDING | 51 | 657 | 1.357e-06 | 0.0003697 |
5 | GROWTH FACTOR RECEPTOR BINDING | 18 | 129 | 2.032e-06 | 0.0003775 |
6 | ACTIN BINDING | 35 | 393 | 3.331e-06 | 0.0005157 |
7 | ENZYME BINDING | 103 | 1737 | 4.398e-06 | 0.0005837 |
8 | CYTOSKELETAL PROTEIN BINDING | 57 | 819 | 9.489e-06 | 0.001016 |
9 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 30 | 328 | 9.845e-06 | 0.001016 |
10 | PROTEIN TYROSINE KINASE ACTIVITY | 20 | 176 | 1.372e-05 | 0.001274 |
11 | PROTEIN KINASE ACTIVITY | 47 | 640 | 1.518e-05 | 0.001282 |
12 | SIGNAL TRANSDUCER ACTIVITY | 100 | 1731 | 1.822e-05 | 0.00141 |
13 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 7 | 25 | 3.038e-05 | 0.001982 |
14 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 28 | 315 | 3.239e-05 | 0.001982 |
15 | PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 13 | 90 | 3.627e-05 | 0.001982 |
16 | PROTEIN COMPLEX BINDING | 61 | 935 | 3.247e-05 | 0.001982 |
17 | BINDING BRIDGING | 19 | 173 | 3.607e-05 | 0.001982 |
18 | KINASE ACTIVITY | 56 | 842 | 4.074e-05 | 0.002102 |
19 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 12 | 81 | 5.571e-05 | 0.002584 |
20 | ACTIN FILAMENT BINDING | 15 | 121 | 5.88e-05 | 0.002584 |
21 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 22 | 228 | 6.675e-05 | 0.002584 |
22 | MOLECULAR FUNCTION REGULATOR | 80 | 1353 | 6.26e-05 | 0.002584 |
23 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 22 | 226 | 5.85e-05 | 0.002584 |
24 | PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 11 | 70 | 6.507e-05 | 0.002584 |
25 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 44 | 629 | 8.821e-05 | 0.003195 |
26 | RECEPTOR ACTIVITY | 93 | 1649 | 8.942e-05 | 0.003195 |
27 | MACROMOLECULAR COMPLEX BINDING | 81 | 1399 | 0.0001131 | 0.00389 |
28 | IDENTICAL PROTEIN BINDING | 72 | 1209 | 0.0001191 | 0.003953 |
29 | GATED CHANNEL ACTIVITY | 27 | 325 | 0.0001395 | 0.004181 |
30 | SH3 DOMAIN BINDING | 14 | 116 | 0.0001375 | 0.004181 |
31 | PHOSPHOLIPID BINDING | 29 | 360 | 0.0001371 | 0.004181 |
32 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 10 | 64 | 0.0001459 | 0.004236 |
33 | PROTEIN KINASE A BINDING | 8 | 42 | 0.0001629 | 0.004585 |
34 | X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 5 | 15 | 0.0001751 | 0.00461 |
35 | CALMODULIN BINDING | 18 | 179 | 0.0001786 | 0.00461 |
36 | PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 5 | 15 | 0.0001751 | 0.00461 |
37 | PROTEIN PHOSPHATASE BINDING | 14 | 120 | 0.0001976 | 0.004754 |
38 | X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 8 | 43 | 0.0001935 | 0.004754 |
39 | PHOSPHORIC ESTER HYDROLASE ACTIVITY | 29 | 368 | 0.0001996 | 0.004754 |
40 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 34 | 464 | 0.0002346 | 0.00545 |
41 | PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 5 | 16 | 0.0002468 | 0.005591 |
42 | GROWTH FACTOR BINDING | 14 | 123 | 0.0002564 | 0.005671 |
43 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 25 | 303 | 0.0002699 | 0.005832 |
44 | HEPARIN BINDING | 16 | 157 | 0.000345 | 0.007284 |
45 | CYCLIC NUCLEOTIDE BINDING | 7 | 36 | 0.0003659 | 0.007554 |
46 | REGULATORY REGION NUCLEIC ACID BINDING | 51 | 818 | 0.0004219 | 0.008521 |
47 | PHOSPHATASE BINDING | 16 | 162 | 0.00049 | 0.009685 |
48 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 59 | 992 | 0.0005087 | 0.009845 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 98 | 1151 | 4.992e-14 | 2.916e-11 |
2 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 123 | 1649 | 3.059e-13 | 8.933e-11 |
3 | SYNAPSE | 71 | 754 | 2.044e-12 | 3.361e-10 |
4 | NEURON PROJECTION | 82 | 942 | 2.302e-12 | 3.361e-10 |
5 | NEURON PART | 97 | 1265 | 3.128e-11 | 3.653e-09 |
6 | POSTSYNAPSE | 43 | 378 | 1.758e-10 | 1.711e-08 |
7 | CELL SUBSTRATE JUNCTION | 44 | 398 | 2.712e-10 | 2.262e-08 |
8 | CELL SURFACE | 66 | 757 | 3.506e-10 | 2.559e-08 |
9 | MEMBRANE REGION | 86 | 1134 | 8.036e-10 | 5.215e-08 |
10 | SYNAPSE PART | 56 | 610 | 1.265e-09 | 7.387e-08 |
11 | MEMBRANE MICRODOMAIN | 35 | 288 | 1.556e-09 | 8.261e-08 |
12 | SOMATODENDRITIC COMPARTMENT | 58 | 650 | 1.843e-09 | 8.967e-08 |
13 | PLASMA MEMBRANE PROTEIN COMPLEX | 49 | 510 | 3.211e-09 | 1.443e-07 |
14 | CELL PROJECTION | 117 | 1786 | 4.112e-09 | 1.715e-07 |
15 | DENDRITE | 43 | 451 | 3.75e-08 | 1.46e-06 |
16 | ANCHORING JUNCTION | 45 | 489 | 5.172e-08 | 1.888e-06 |
17 | RECEPTOR COMPLEX | 34 | 327 | 1.325e-07 | 4.55e-06 |
18 | ACTIN CYTOSKELETON | 41 | 444 | 1.86e-07 | 5.881e-06 |
19 | SIDE OF MEMBRANE | 40 | 428 | 1.913e-07 | 5.881e-06 |
20 | CELL CORTEX | 27 | 238 | 4.673e-07 | 1.365e-05 |
21 | CYTOPLASMIC REGION | 30 | 287 | 6.442e-07 | 1.739e-05 |
22 | CELL LEADING EDGE | 34 | 350 | 6.553e-07 | 1.739e-05 |
23 | I BAND | 18 | 121 | 7.831e-07 | 1.988e-05 |
24 | PLASMA MEMBRANE RECEPTOR COMPLEX | 22 | 175 | 9.516e-07 | 2.316e-05 |
25 | PLASMA MEMBRANE REGION | 65 | 929 | 1.846e-06 | 4.313e-05 |
26 | PERINUCLEAR REGION OF CYTOPLASM | 49 | 642 | 3.512e-06 | 7.64e-05 |
27 | NEURON SPINE | 17 | 121 | 3.532e-06 | 7.64e-05 |
28 | POSTSYNAPTIC MEMBRANE | 23 | 205 | 3.943e-06 | 8.223e-05 |
29 | MEMBRANE PROTEIN COMPLEX | 68 | 1020 | 5.555e-06 | 0.0001119 |
30 | CONTRACTILE FIBER | 23 | 211 | 6.408e-06 | 0.0001248 |
31 | EXCITATORY SYNAPSE | 22 | 197 | 6.859e-06 | 0.0001281 |
32 | CELL BODY | 40 | 494 | 7.02e-06 | 0.0001281 |
33 | EXTRACELLULAR MATRIX | 36 | 426 | 7.904e-06 | 0.0001399 |
34 | SYNAPTIC MEMBRANE | 26 | 261 | 8.532e-06 | 0.0001466 |
35 | INTRACELLULAR VESICLE | 79 | 1259 | 8.965e-06 | 0.0001496 |
36 | GOLGI APPARATUS | 87 | 1445 | 1.499e-05 | 0.0002432 |
37 | SITE OF POLARIZED GROWTH | 18 | 149 | 1.587e-05 | 0.0002504 |
38 | EXTRACELLULAR SPACE | 82 | 1376 | 3.847e-05 | 0.0005913 |
39 | T TUBULE | 9 | 45 | 4.255e-05 | 0.0006371 |
40 | PROTEINACEOUS EXTRACELLULAR MATRIX | 30 | 356 | 4.674e-05 | 0.0006824 |
41 | FILOPODIUM | 13 | 94 | 5.778e-05 | 0.0008231 |
42 | ENDOPLASMIC RETICULUM | 93 | 1631 | 5.997e-05 | 0.0008339 |
43 | DENDRITIC SHAFT | 8 | 37 | 6.306e-05 | 0.0008564 |
44 | CYTOPLASMIC SIDE OF MEMBRANE | 18 | 170 | 9.255e-05 | 0.001228 |
45 | CELL PROJECTION PART | 59 | 946 | 0.0001503 | 0.00195 |
46 | AXON | 32 | 418 | 0.0001624 | 0.002062 |
47 | VACUOLE | 70 | 1180 | 0.0001664 | 0.002068 |
48 | CILIARY BASE | 6 | 23 | 0.0001761 | 0.002142 |
49 | TRANSPORTER COMPLEX | 26 | 321 | 0.0002742 | 0.003269 |
50 | EXTRACELLULAR MATRIX COMPONENT | 14 | 125 | 0.0003035 | 0.003475 |
51 | SARCOLEMMA | 14 | 125 | 0.0003035 | 0.003475 |
52 | LAMELLIPODIUM | 17 | 172 | 0.0003281 | 0.003685 |
53 | ENDOCYTIC VESICLE | 22 | 256 | 0.000353 | 0.00389 |
54 | PLASMA MEMBRANE RAFT | 11 | 86 | 0.0004232 | 0.004577 |
55 | PLATELET ALPHA GRANULE | 10 | 75 | 0.0005478 | 0.005817 |
56 | CYTOSKELETON | 102 | 1967 | 0.0008519 | 0.008728 |
57 | CELL CELL JUNCTION | 28 | 383 | 0.0008375 | 0.008728 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04010_MAPK_signaling_pathway | 32 | 268 | 1.204e-08 | 2.167e-06 | |
2 | hsa04014_Ras_signaling_pathway | 29 | 236 | 3.072e-08 | 2.764e-06 | |
3 | hsa04151_PI3K_AKT_signaling_pathway | 33 | 351 | 1.97e-06 | 0.0001182 | |
4 | hsa04270_Vascular_smooth_muscle_contraction | 16 | 116 | 8.65e-06 | 0.0003893 | |
5 | hsa04730_Long.term_depression | 12 | 70 | 1.23e-05 | 0.0004428 | |
6 | hsa04210_Apoptosis | 13 | 89 | 3.213e-05 | 0.000964 | |
7 | hsa04020_Calcium_signaling_pathway | 18 | 177 | 0.000155 | 0.003549 | |
8 | hsa04540_Gap_junction | 12 | 90 | 0.0001577 | 0.003549 | |
9 | hsa04810_Regulation_of_actin_cytoskeleton | 20 | 214 | 0.0002167 | 0.004333 | |
10 | hsa04380_Osteoclast_differentiation | 14 | 128 | 0.0003879 | 0.006982 | |
11 | hsa04912_GnRH_signaling_pathway | 12 | 101 | 0.0004686 | 0.007669 | |
12 | hsa04510_Focal_adhesion | 18 | 200 | 0.0006883 | 0.01032 | |
13 | hsa04512_ECM.receptor_interaction | 10 | 85 | 0.00147 | 0.01957 | |
14 | hsa04710_Circadian_rhythm_._mammal | 5 | 23 | 0.001522 | 0.01957 | |
15 | hsa04520_Adherens_junction | 9 | 73 | 0.001802 | 0.01983 | |
16 | hsa04640_Hematopoietic_cell_lineage | 10 | 88 | 0.001915 | 0.01983 | |
17 | hsa04310_Wnt_signaling_pathway | 14 | 151 | 0.001974 | 0.01983 | |
18 | hsa04971_Gastric_acid_secretion | 9 | 74 | 0.001983 | 0.01983 | |
19 | hsa04062_Chemokine_signaling_pathway | 16 | 189 | 0.002504 | 0.02372 | |
20 | hsa04145_Phagosome | 14 | 156 | 0.002672 | 0.02404 | |
21 | hsa04722_Neurotrophin_signaling_pathway | 12 | 127 | 0.003446 | 0.02954 | |
22 | hsa04972_Pancreatic_secretion | 10 | 101 | 0.005244 | 0.0429 | |
23 | hsa04672_Intestinal_immune_network_for_IgA_production | 6 | 49 | 0.01053 | 0.0824 | |
24 | hsa00565_Ether_lipid_metabolism | 5 | 36 | 0.01134 | 0.08507 | |
25 | hsa04920_Adipocytokine_signaling_pathway | 7 | 68 | 0.01487 | 0.0982 | |
26 | hsa04916_Melanogenesis | 9 | 101 | 0.01517 | 0.0982 | |
27 | hsa04390_Hippo_signaling_pathway | 12 | 154 | 0.01523 | 0.0982 | |
28 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 11 | 136 | 0.01528 | 0.0982 | |
29 | hsa04630_Jak.STAT_signaling_pathway | 12 | 155 | 0.01596 | 0.0984 | |
30 | hsa04720_Long.term_potentiation | 7 | 70 | 0.01724 | 0.0984 | |
31 | hsa04142_Lysosome | 10 | 121 | 0.01761 | 0.0984 | |
32 | hsa04012_ErbB_signaling_pathway | 8 | 87 | 0.01804 | 0.0984 | |
33 | hsa04914_Progesterone.mediated_oocyte_maturation | 8 | 87 | 0.01804 | 0.0984 | |
34 | hsa04970_Salivary_secretion | 8 | 89 | 0.02042 | 0.1081 | |
35 | hsa00230_Purine_metabolism | 12 | 162 | 0.0218 | 0.1121 | |
36 | hsa04614_Renin.angiotensin_system | 3 | 17 | 0.02531 | 0.1246 | |
37 | hsa04370_VEGF_signaling_pathway | 7 | 76 | 0.0259 | 0.1246 | |
38 | hsa00591_Linoleic_acid_metabolism | 4 | 30 | 0.02631 | 0.1246 | |
39 | hsa04360_Axon_guidance | 10 | 130 | 0.02745 | 0.1267 | |
40 | hsa04612_Antigen_processing_and_presentation | 7 | 78 | 0.02935 | 0.1305 | |
41 | hsa04975_Fat_digestion_and_absorption | 5 | 46 | 0.03025 | 0.1305 | |
42 | hsa04114_Oocyte_meiosis | 9 | 114 | 0.03061 | 0.1305 | |
43 | hsa04664_Fc_epsilon_RI_signaling_pathway | 7 | 79 | 0.03118 | 0.1305 | |
44 | hsa04514_Cell_adhesion_molecules_.CAMs. | 10 | 136 | 0.03587 | 0.1467 | |
45 | hsa00592_alpha.Linolenic_acid_metabolism | 3 | 20 | 0.039 | 0.1527 | |
46 | hsa04910_Insulin_signaling_pathway | 10 | 138 | 0.03903 | 0.1527 | |
47 | hsa04620_Toll.like_receptor_signaling_pathway | 8 | 102 | 0.04149 | 0.1589 | |
48 | hsa04130_SNARE_interactions_in_vesicular_transport | 4 | 36 | 0.04733 | 0.1741 | |
49 | hsa04610_Complement_and_coagulation_cascades | 6 | 69 | 0.04792 | 0.1741 | |
50 | hsa04144_Endocytosis | 13 | 203 | 0.04835 | 0.1741 | |
51 | hsa04660_T_cell_receptor_signaling_pathway | 8 | 108 | 0.05484 | 0.1935 | |
52 | hsa00590_Arachidonic_acid_metabolism | 5 | 59 | 0.07429 | 0.2514 | |
53 | hsa04621_NOD.like_receptor_signaling_pathway | 5 | 59 | 0.07429 | 0.2514 | |
54 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 4 | 42 | 0.07542 | 0.2514 | |
55 | hsa00920_Sulfur_metabolism | 2 | 13 | 0.08606 | 0.2725 | |
56 | hsa02010_ABC_transporters | 4 | 44 | 0.08629 | 0.2725 | |
57 | hsa04962_Vasopressin.regulated_water_reabsorption | 4 | 44 | 0.08629 | 0.2725 | |
58 | hsa04974_Protein_digestion_and_absorption | 6 | 81 | 0.0893 | 0.2771 | |
59 | hsa04350_TGF.beta_signaling_pathway | 6 | 85 | 0.1064 | 0.3245 | |
60 | hsa00120_Primary_bile_acid_biosynthesis | 2 | 16 | 0.1229 | 0.3688 | |
61 | hsa03320_PPAR_signaling_pathway | 5 | 70 | 0.1291 | 0.3808 | |
62 | hsa04976_Bile_secretion | 5 | 71 | 0.1348 | 0.3858 | |
63 | hsa00450_Selenocompound_metabolism | 2 | 17 | 0.136 | 0.3858 | |
64 | hsa04530_Tight_junction | 8 | 133 | 0.1372 | 0.3858 | |
65 | hsa04670_Leukocyte_transendothelial_migration | 7 | 117 | 0.1606 | 0.4374 | |
66 | hsa00531_Glycosaminoglycan_degradation | 2 | 19 | 0.1628 | 0.4374 | |
67 | hsa04623_Cytosolic_DNA.sensing_pathway | 4 | 56 | 0.1653 | 0.4376 | |
68 | hsa04260_Cardiac_muscle_contraction | 5 | 77 | 0.1712 | 0.4466 | |
69 | hsa00620_Pyruvate_metabolism | 3 | 40 | 0.1957 | 0.5032 | |
70 | hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate | 2 | 22 | 0.2046 | 0.5186 | |
71 | hsa00760_Nicotinate_and_nicotinamide_metabolism | 2 | 24 | 0.233 | 0.5745 | |
72 | hsa00510_N.Glycan_biosynthesis | 3 | 49 | 0.2879 | 0.7003 | |
73 | hsa00512_Mucin_type_O.Glycan_biosynthesis | 2 | 30 | 0.3188 | 0.7524 | |
74 | hsa04150_mTOR_signaling_pathway | 3 | 52 | 0.3195 | 0.7524 | |
75 | hsa04662_B_cell_receptor_signaling_pathway | 4 | 75 | 0.3219 | 0.7524 | |
76 | hsa04070_Phosphatidylinositol_signaling_system | 4 | 78 | 0.3481 | 0.8032 | |
77 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.3617 | 0.8225 | |
78 | hsa00564_Glycerophospholipid_metabolism | 4 | 80 | 0.3655 | 0.8225 | |
79 | hsa04140_Regulation_of_autophagy | 2 | 34 | 0.3749 | 0.8331 | |
80 | hsa00600_Sphingolipid_metabolism | 2 | 40 | 0.4551 | 0.9752 | |
81 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 4 | 95 | 0.4938 | 1 | |
82 | hsa04115_p53_signaling_pathway | 3 | 69 | 0.4939 | 1 | |
83 | hsa00310_Lysine_degradation | 2 | 44 | 0.5051 | 1 | |
84 | hsa04622_RIG.I.like_receptor_signaling_pathway | 3 | 71 | 0.513 | 1 | |
85 | hsa00561_Glycerolipid_metabolism | 2 | 50 | 0.5744 | 1 | |
86 | hsa04146_Peroxisome | 3 | 79 | 0.5856 | 1 | |
87 | hsa00330_Arginine_and_proline_metabolism | 2 | 54 | 0.6165 | 1 | |
88 | hsa03015_mRNA_surveillance_pathway | 3 | 83 | 0.6192 | 1 | |
89 | hsa00140_Steroid_hormone_biosynthesis | 2 | 57 | 0.6459 | 1 | |
90 | hsa04110_Cell_cycle | 4 | 128 | 0.7254 | 1 | |
91 | hsa03018_RNA_degradation | 2 | 71 | 0.7601 | 1 | |
92 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 5 | 168 | 0.7736 | 1 | |
93 | hsa04120_Ubiquitin_mediated_proteolysis | 4 | 139 | 0.7823 | 1 | |
94 | hsa03013_RNA_transport | 4 | 152 | 0.837 | 1 | |
95 | hsa00240_Pyrimidine_metabolism | 2 | 99 | 0.8963 | 1 | |
96 | hsa04740_Olfactory_transduction | 3 | 388 | 1 | 1 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | RP11-967K21.1 | hsa-miR-140-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-29b-2-5p;hsa-miR-32-3p;hsa-miR-335-5p;hsa-miR-362-5p;hsa-miR-769-5p | 10 | EGFR | Sponge network | -1.206 | 0.01654 | -0.229 | 0.5939 | 0.378 |
2 | LINC00883 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-3913-5p | 10 | EGFR | Sponge network | -0.614 | 0.0511 | -0.229 | 0.5939 | 0.376 |
3 | AC002066.1 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-3913-5p;hsa-miR-7-1-3p | 10 | EGFR | Sponge network | -1.314 | 0.04594 | -0.229 | 0.5939 | 0.355 |
4 | AC005682.5 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-362-5p;hsa-miR-769-5p | 12 | EGFR | Sponge network | -0.787 | 0.08468 | -0.229 | 0.5939 | 0.338 |
5 | RP11-356J5.12 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-140-5p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-320a;hsa-miR-335-5p;hsa-miR-7-1-3p;hsa-miR-769-5p | 15 | EGFR | Sponge network | -2.015 | 0 | -0.229 | 0.5939 | 0.286 |
6 | RP11-411K7.1 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-140-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-195-3p;hsa-miR-200a-3p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-374a-3p;hsa-miR-3913-5p;hsa-miR-7-1-3p | 13 | EGFR | Sponge network | -0.894 | 0.3797 | -0.229 | 0.5939 | 0.283 |
7 | RP3-439F8.1 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-148b-5p;hsa-miR-17-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-200a-3p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-374b-3p | 11 | EGFR | Sponge network | -0.149 | 0.78031 | -0.229 | 0.5939 | 0.27 |
8 | RP11-890B15.2 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-148b-5p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-3913-5p;hsa-miR-769-5p | 11 | EGFR | Sponge network | 0.169 | 0.82185 | -0.229 | 0.5939 | 0.26 |
9 | RP11-221J22.2 | hsa-miR-125a-5p;hsa-miR-128-3p;hsa-miR-186-5p;hsa-miR-192-5p;hsa-miR-29b-2-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-3913-5p;hsa-miR-769-5p | 10 | EGFR | Sponge network | 0.439 | 0.66705 | -0.229 | 0.5939 | 0.258 |